These numbers explain why a recent poll found that one in eight adults in the US say they use GLP-1 drugs, many for weight loss and others for diabetes
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4):A randomised, double-blind, phase 3a trial [published correction appears in Lancet 2019;394:e1] Lancet
It's on the World Health Organizations list of essential medicines approved to treat poisoning
IDF, 2021
Capy, the AI companion built only for GLP-1, lives inside the app that already knows your logs, so you can ask real questions in the moment: why the chatter feels louder this week, what a rough patch after a dose step usually looks like, ideas for meals when appetite is quiet but protein still matters
Across the wider UK peptides market, this helps researchers compare suppliers using documented evidence rather than relying on general purity claims